GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OSTO:BIOT) » Definitions » Cyclically Adjusted PB Ratio

Biotage AB (OSTO:BIOT) Cyclically Adjusted PB Ratio : 9.61 (As of May. 17, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biotage AB Cyclically Adjusted PB Ratio?

As of today (2024-05-17), Biotage AB's current share price is kr179.50. Biotage AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr18.67. Biotage AB's Cyclically Adjusted PB Ratio for today is 9.61.

The historical rank and industry rank for Biotage AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:BIOT' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.22   Med: 13.35   Max: 26.88
Current: 9.1

During the past years, Biotage AB's highest Cyclically Adjusted PB Ratio was 26.88. The lowest was 5.22. And the median was 13.35.

OSTO:BIOT's Cyclically Adjusted PB Ratio is ranked worse than
89.29% of 467 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs OSTO:BIOT: 9.10

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biotage AB's adjusted book value per share data for the three months ended in Mar. 2024 was kr48.608. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr18.67 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotage AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biotage AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Cyclically Adjusted PB Ratio Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.41 14.47 23.78 13.33 7.56

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.17 8.58 6.44 7.56 9.74

Competitive Comparison of Biotage AB's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Biotage AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotage AB's Cyclically Adjusted PB Ratio falls into.



Biotage AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biotage AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=179.50/18.67
=9.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotage AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Biotage AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=48.608/132.2054*132.2054
=48.608

Current CPI (Mar. 2024) = 132.2054.

Biotage AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 7.181 100.432 9.453
201409 7.429 100.161 9.806
201412 7.976 100.225 10.521
201503 8.200 99.950 10.846
201506 7.666 99.995 10.135
201509 7.944 100.228 10.479
201512 8.447 100.276 11.137
201603 8.718 100.751 11.440
201606 7.885 101.019 10.319
201609 8.337 101.138 10.898
201612 8.703 102.022 11.278
201703 9.209 102.022 11.934
201706 8.432 102.752 10.849
201709 8.802 103.279 11.267
201712 9.405 103.793 11.980
201803 10.192 103.962 12.961
201806 9.772 104.875 12.319
201809 10.408 105.679 13.021
201812 10.769 105.912 13.443
201903 12.693 105.886 15.848
201906 11.995 106.742 14.856
201909 13.305 107.214 16.406
201912 13.428 107.766 16.473
202003 14.697 106.563 18.234
202006 14.758 107.498 18.150
202009 15.171 107.635 18.634
202012 15.184 108.296 18.536
202103 16.599 108.360 20.252
202106 15.636 108.928 18.977
202109 16.702 110.338 20.012
202112 20.778 112.486 24.421
202203 22.051 114.825 25.389
202206 22.445 118.384 25.066
202209 24.233 122.296 26.197
202212 24.809 126.365 25.956
202303 25.582 127.042 26.622
202306 46.861 129.407 47.875
202309 46.108 130.224 46.810
202312 45.708 131.912 45.810
202403 48.608 132.205 48.608

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotage AB  (OSTO:BIOT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biotage AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biotage AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (OSTO:BIOT) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (OSTO:BIOT) Headlines

From GuruFocus

Biotech Acquisition Company Announces Liquidation

By GlobeNewswire GlobeNewswire 02-02-2023

Biotech Acquisition Company Announces Liquidation

By Stock market mentor Stock market mentor 02-02-2023